From Gautam Menon, Walsall, West Midlands, UK
The idea of implanting a hypoxia-inducing battery near cancerous tissue to improve the function of hypoxia-activated prodrugs (HAPs) for cancer treatment was thought-provoking. You also had an article on the human electrome (25 February, p 38) that commented on cellular voltage patterns and the characteristic electrical signatures of cancer cells(8 April, p 8).
I wonder if changes to the electrome could be induced with implanted devices to propagate a hypoxic milieu and further boost the action of HAPs on cancers.
